| Literature DB >> 25352504 |
Antonio Eduardo Monteiro de Almeida1, Charles de Moraes Stefani2, João Agnaldo do Nascimento3, Narla Miranda de Almeida1, Amilton da Cruz Santos3, Jorge Pinto Ribeiro4, Ricardo Stein2.
Abstract
BACKGROUND: The equations predicting maximal oxygen uptake (VO2max or peak) presently in use in cardiopulmonary exercise testing (CPET) softwares in Brazil have not been adequately validated. These equations are very important for the diagnostic capacity of this method.Entities:
Mesh:
Year: 2014 PMID: 25352504 PMCID: PMC4206360
Source DB: PubMed Journal: Arq Bras Cardiol ISSN: 0066-782X Impact factor: 2.000
Figure 1Flowchart for study population selection.
CAD: chronic arterial disease; COPD: chronic obstructive pulmonary disease; CG: construction group; VG: validation group; SAH: systemic arterial hypertension; CHF: congestive heart failure; TP: technical problems; LCMC: lack of the criteria for maximal CPET; CPET: cardiopulmonary exercise testing.
General profile of the construction group (n = 2,495)
| Characteristics | Data (Mean ± SD or %) | Minimum | Maximum | |
|---|---|---|---|---|
| Age (years) | 42.57 ± 15.00 | 8 | 90 | |
| Gender | Male | 1,286 (51.5) | - | - |
| Female | 1,209 (48.5) | - | - | |
| Weight (Kg) | 73.71 ± 16.02 | 37.5 | 149.5 | |
| Height (m) | 1.65 ± 0.10 | 1.33 | 2.00 | |
| BMI | 27.15 ± 5.00 | 14.53 | 66.93 | |
| Physical activity | Sedentary | 1,280 (51.3) | - | - |
| Active | 1,107 (44.4) | - | - | |
| Athletic | 108 (4.3) | - | - |
SD: standard deviation; BMI: body mass index.
General profile of the validation group (n = 624)
| Characteristics | Data (Mean ± SD or %) | Minimum | Maximum | |
|---|---|---|---|---|
| Age (years) | 41.28 ± 14.47 | 11 | 84 | |
| Gender | Male | 338 (54.2) | - | - |
| Female | 286 (45.8) | - | - | |
| Weight (Kg) | 74.10 ± 15.85 | 36.8 | 134.7 | |
| Height (m) | 1.65 ± 0.10 | 1.38 | 1.93 | |
| BMI | 27.10 ± 5.02 | 16.20 | 51.70 | |
| Physical activity | Sedentary | 318 (51.0) | - | - |
| Active | 278 (44.6) | - | - | |
| Athletic | 28 (4.5) | - | - |
SD: standard deviation; BMI: body mass index.
Figure 2Scatter plot of oxygen consumption by gender.
Complete blood count, 2D-color Doppler echocardiography, spirometry, and CPET results
| Variables | Construction (n = 2,495) | Validation (n = 624) | p value | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Mean | ± SD | Minimum | Maximum | Mean | ± SD | Minimum | Maximum | ||
| Hemoglobin (g/dL) | 13.65 | 0.97 | 12.00 | 16.90 | 13.60 | 0.96 | 12.00 | 15.90 | 0.307 |
| Hematocrit (%) | 42.45 | 3.35 | 37.00 | 50.80 | 42.63 | 3.13 | 38.00 | 51.80 | 0.183 |
| Ejection fraction (%) | 67.02 | 6.05 | 56.00 | 79.00 | 66.95 | 6.18 | 55.00 | 80.00 | 0.808 |
| FVC (L) | 3.67 | 0.97 | 1.76 | 6.83 | 3.66 | 0.99 | 1.81 | 6.71 | 0.859 |
| FEV1 (L) | 3.15 | 0.80 | 1.66 | 5.65 | 3.14 | 0.81 | 1.74 | 5.32 | 0.719 |
| FEV1/FVC (%) | 87.18 | 4.79 | 80.12 | 95.85 | 87.07 | 4.71 | 80.20 | 95.39 | 0.589 |
| Speed (Km/h) | 7.72 | 1.66 | 3.20 | 17.20 | 7.84 | 1.72 | 4.0 | 15.50 | 0.117 |
| Inclination (%) | 9.68 | 3.02 | 1.50 | 19.00 | 9.65 | 2.98 | 2.00 | 21.00 | 0.908 |
| Duration of the effort (s) | 535.55 | 124.0 | 313 | 1169 | 531.53 | 125.0 | 312 | 1090 | 0.472 |
| Max HR (bpm) | 173.26 | 15.44 | 119 | 209 | 175.12 | 16.90 | 125 | 208 | 0.013 |
| Max SBP (mmHg) | 185.82 | 23.86 | 122 | 257 | 184.36 | 22.76 | 131 | 254 | 0.157 |
| Max DBP (mmHg) | 89.78 | 12.11 | 64 | 126 | 88.84 | 11.03 | 66 | 123 | 0.063 |
| Respiratory coefficient ® | 1.15 | 0.06 | 1.10 | 1.38 | 1.16 | 0.07 | 1.10 | 1.35 | 0.356 |
| Max MV (L/min) | 75.32 | 15.78 | 33.10 | 121.9 | 74.99 | 15.55 | 39.50 | 118.10 | 0.639 |
| Abs VO2peak (L/min) | 2.16 | 0.82 | 1.02 | 4.82 | 2.22 | 0.84 | 0.99 | 4.98 | 0.087 |
FVC: forced vital capacity; SD: standard deviation; Max HR: maximum heart rate; Max DBP: maximum diastolic blood pressure; Max SBP: maximum systolic blood pressure; R: respiratory quotient; FEV1: forced expiratory volume in 1 s; Max MV: maximum minute ventilation; Abs VO2peak: absolute peak oxygen consumption.
Statistical values of the equations in CG and VG
| Phase | Statistic measurements | Measured VO2 | BE | Jones | Wasserman |
|---|---|---|---|---|---|
| Construction | Mean | 29.22 | 29.22 | 38.41 | 32.53 |
| Minimum | 12.93 | 12.78 | 13.32 | 13.86 | |
| Maximum | 65.56 | 58.81 | 61.72 | 65.38 | |
| Standard deviation | 9.57 | 7.88 | 8.39 | 8.54 | |
| ESE | - | 4.46 | 6.54 | 5.77 | |
| TE | - | 5.38 | 12.07 | 7.41 | |
| %TE | - | 18.43 | 41.30 | 25.36 | |
| Validation | Mean | 29.92 | 29.80 | 39.23 | 33.25 |
| Minimum | 12.21 | 11.23 | 15.32 | 16.04 | |
| Maximum | 66.52 | 54.32 | 59.27 | 59.25 | |
| Standard deviation | 9.82 | 7.87 | 8.27 | 8.59 | |
| ESE | - | 4.32 | 6.44 | 5.89 | |
| TE | - | 5.40 | 12.23 | 7.64 | |
| %TE | - | 18.05 | 40.87 | 25.55 |
EB: equation derived from a Brazilian population; ESE: estimated standard error; TE: total error; %TE: percentage of total error; VO2: oxygen consumption. VO2peak values were expressed as mL.kg−1.min−1.
Comparison of measured and predicted peak VO2 values using different equations in CG and VG
| Comparison | CG | VG | ||
|---|---|---|---|---|
| 95% CI | p value | 95% CI | p value | |
| VO2peak × Brazilian | -0.213 a 0.213 | 0.999 | -0.302 a 0.547 | 0.571 |
| VO2peak × Wasserman | -3.568 a -3.047 | 0.001 | -3.877 a 2.794 | 0.001 |
| VO2peak × Jones | 9.492 a -8.877 | 0.001 | -9.937 a -8.690 | 0.001 |
Student’s paired t-test. CI: confidence interval;
VO2peak: peak oxygen consumption; CG: construction group; VG: validation group.
Distribution of positive and negative equation residues in CG and VG
| Residues | CG | VG | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| National | Wasserman | Jones | National | Wasserman | Jones | |||||||
| n | % | n | % | n | % | n | % | n | % | n | % | |
| Negative | 1,243 | 49.82 | 1,805 | 72.34 | 2,186 | 87.62 | 315 | 50.48 | 441 | 70.67 | 547 | 87.66 |
| Positive | 1,252 | 50.18 | 690 | 27.66 | 309 | 12.38 | 309 | 49.52 | 183 | 29.33 | 77 | 12.34 |
| p value | 0.857 | 0.001 | 0.001 | 0.810 | 0.001 | 0.001 | ||||||
Chi-square test.
CG: construction group; VG: validation group.